FDA Approves First Drug for Postpartum Depression
WEDNESDAY, March 20, 2019 (HealthDay News) — Postpartum depression is a common and often devastating condition for new mothers, but the U.S. Food and Drug Administration on Tuesday approved the first drug to help combat it. The drug, Zulesso (brexanolone), is delivered via intravenous infusion. “Postpartum depression is a seriousContinue Reading












